Participants’ Accounts on Their Decision to Join a Cohort Study With an Attached Biobank

Abstract

Reliable participation and sustained retention rates are crucial in longitudinal studies involving human subjects and biomaterials. Understanding the decision to enroll is an essential step to develop adequate strategies promoting long-term participation. Semi-structured interviews were implemented with newly recruited and long-term participants randomly drawn from two ongoing longitudinal studies with a biobank component in Germany. Iterative qualitative content analysis was applied to the transcribed interviews. Participants (n = 31) expressed their decision to enroll or remain in the study as the result of the complex interplay of individual factors, institutional cues, study-related features, and societal dynamics. Different forms of trust were identified as central within the elements used to explain participation and could be compared to Dibben, Morris, and Lean’s dynamic model of interpersonal trust. Given these high levels of trust, an investigation of the morality of the trustful relationship at stake between participants and research(ers) is warranted.

Keywords

cohort study biobank participation decision qualitative interviews trust Germany

Get full access to this article

View all access options for this article.

References

Appelbaum

P. S.

Grisso

(1988). Assessing patients’ capacities to consent to treatment. The New England Journal of Medicine, 319, 1635-1638. doi:10.1056/NEJM198812223192504

Appelbaum

P. S.

Roth

L. H.

Lidz

C. W.

Benson

Winslade

(1987). False hopes and best data: Consent to research and the therapeutic misconception. Hastings Center Report, 17(2), 20-24.

Bergmann

M. M.

Bussas

Boeing

(1999). Follow-up procedures in EPIC-Germany—Data quality aspects. European Prospective Investigation into Cancer and Nutrition. Annals of Nutrition and Metabolism, 43, 225-234. doi:10.1159/000012789

Boeing

Korfmann

Bergmann

M. M.

(1999). Recruitment procedures of EPIC-Germany. European Investigation into Cancer and Nutrition. Annals of Nutrition and Metabolism, 43, 205-215. doi:10.1159/000012787

Boeing

Wahrendorf

Becker

(1999). EPIC-Germany—A source for studies into diet and risk of chronic diseases. European Investigation into Cancer and Nutrition. Annals of Nutrition and Metabolism, 43, 195-204. doi:10.1159/000012786

Boyd

(2015). The impossibility of informed consent? Journal of Medical Ethics, 41, 44-47. doi:10.1136/medethics-2014-102308

Brekke

O. A.

Sirnes

(2006). Population biobanks: The ethical gravity of informed consent. BioSocieties, 1, 385-398.

Childress

J. F.

Fletcher

J. C.

(1994). Respect for autonomy. Hastings Center Report, 24(3), 34-35.

Corrigan

(2003). Empty ethics: The problem with informed consent. Sociology of Health & Illness, 25, 768-792.

10.

Council of Europe. (2006). Recommendation Rec(2006)4 of the Committee of Ministers to member states on research on biological materials of human origin https://search.coe.int/cm/Pages/result_details.aspx?ObjectID=09000016805d84f0

11.

Critchley

Nicol

Otlowski

(2015). The impact of commercialisation and genetic data sharing arrangements on public trust and the intention to participate in biobank research. Public Health Genomics, 18, 160-172. doi:10.1159/000375441

12.

Dibben

M. R.

(2001). Trust as Process: A Study in the Application of Whiteheadian Thinking to Emotional Experiences. Concrescence: The Australian Journal of Process Thought, 2, 22-34.

13.

Dibben

M. R.

Morris

S. E.

Lean

M. E.

(2000). Situational trust and co-operative partnerships between physicians and their patients: A theoretical explanation transferable from business practice. QJM, 93(1), 55-61.

14.

Dixon-Woods

Ashcroft

R. E.

Jackson

C. J.

Tobin

M. D.

Kivits

Burton

P. R.

Samani

N. J.

(2007). Beyond “misunderstanding”: Written information and decisions about taking part in a genetic epidemiology study. Social Science & Medicine, 65, 2212-2222.

15.

Dixon-Woods

Tarrant

(2009). Why do people cooperate with medical research? Findings from three studies. Social Science & Medicine, 68, 2215-2222. doi:10.1016/j.socscimed.2009.03.034

16.

Ducournau

Strand

(2010). Trust, distrust and co-production: The relationship between research biobanks and donors. In Solbakk

J. H.

Holm

Hofmann

(Eds.), The ethics of research biobanking (pp. 115-130). New York, NY: Springer.

17.

Evers

Forsberg

Hansson

(2012). Commercialization of biobanks. Biopreservation and Biobanking, 10, 45-47. doi:10.1089/bio.2011.0041

18.

Featherstone

Donovan

J. L.

(2002). “Why don’t they just tell me straight, why allocate it?” The struggle to make sense of participating in a randomised controlled trial. Social Science & Medicine, 55, 709-719.

19.

Fry

C. L.

(2008). A comprehensive evidence-based approach is needed for promoting participation in health research: a commentary on Williams. Soc Sci Med, 66(7), 1457-1460; discussion 1461-1452. doi: 10.1016/j.socscimed.2007.12.014

20.

Galea

Tracy

(2007). Participation rates in epidemiologic studies. Annals of Epidemiology, 17, 643-653. doi:10.1016/j.annepidem.2007.03.013

21.

Gaskell

Gottweis

Starkbaum

Gerber

M. M.

Broerse

Gottweis

. . . Soulier

(2013). Publics and biobanks: Pan-European diversity and the challenge of responsible innovation. European Journal of Human Genetics, 21(1), 14-20. doi:10.1038/ejhg.2012.104

22.

German National Cohort. (2015). Fact sheet. Retrieved from http://nako.de/wp-content/uploads/2015/10/2016-03-18_NAKO-Fact-Sheet-EN.pdf

23.

German National Cohort Consortium. (2014). The German National Cohort: Aims, study design and organization. European Journal of Epidemiology, 29, 371-382. doi:10.1007/s10654-014-9890-7

24.

Gracia

(2012). The many faces of autonomy. Theoretical Medicine and Bioethics, 33, 57-64. doi:10.1007/s11017-012-9208-2

25.

Grady

Eckstein

Berkman

Brock

Cook-Deegan

Fullerton

S. M.

. . . Wendler

(2015). Broad consent for research with biological samples: Workshop conclusions. American Journal of Bioethics, 15(9), 34-42. doi:10.1080/15265161.2015.1062162

26.

Hallowell

Cooke

Crawford

Lucassen

Parker

Snowdon

(2010). An investigation of patients’ motivations for their participation in genetics-related research. Journal of Medical Ethics, 36, 37-45.

27.

Halverson

C. M.

Ross

L. F.

(2012a). Attitudes of African-American parents about biobank participation and return of results for themselves and their children. Journal of Medical Ethics, 38, 561-566. doi:10.1136/medethics-2012-100600

28.

Halverson

C. M.

Ross

L. F.

(2012b). Incidental findings of therapeutic misconception in biobank-based research. Genetics in Medicine, 14, 611-615. doi:10.1038/gim.2011.50

29.

Hansson

M. G.

(2005). Building on relationships of trust in biobank research. Journal of Medical Ethics, 31, 415-418. doi:10.1136/jme.2004.009456

30.

Hansson

M. G.

Dillner

Bartram

C. R.

Carlson

J. A.

Helgesson

(2006). Should donors be allowed to give broad consent to future biobank research? The Lancet Oncology, 7, 266-269. doi:10.1016/S1470-2045(06)70618-0

31.

Harris

J. R.

Burton

Knoppers

B. M.

Lindpaintner

Bledsoe

Brookes

A. J.

. . . Zatloukal

(2012). Toward a roadmap in global biobanking for health. European Journal of Human Genetics, 20, 1105-1111. doi:10.1038/ejhg.2012.96

32.

Henderson

Garrett

Bussey-Jones

Moloney

M. E.

Blumenthal

Corbie-Smith

(2008). Great expectations: Views of genetic research participants regarding current and future genetic studies. Genetics in Medicine, 10, 193-200.

33.

Hoeyer

(2003). “Science is really needed—That’s all I know”: Informed consent and the non-verbal practices of collecting blood for genetic research in northern Sweden. New Genetics and Society, 22, 229-244.

34.

Hoeyer

Lynoe

(2006). Motivating donors to genetic research? Anthropological reasons to rethink the role of informed consent. Medicine, Health Care and Philosophy, 9(1), 13-23.

35.

Hofmann

(2009). Broadening consent—And diluting ethics? Journal of Medical Ethics, 35, 125-129. doi:10.1136/jme.2008.024851

36.

Holmberg

Waters

E. A.

Whitehouse

Daly

McCaskill-Stevens

(2015). My lived experiences are more important than your probabilities: The role of individualized risk estimates for decision making about participation in the Study of Tamoxifen and Raloxifene (STAR). Medical Decision Making, 35, 1010-1022. doi:10.1177/0272989X15594382

37.

Joffe

Cook

E. F.

Cleary

P. D.

Clark

J. W.

Weeks

J. C.

(2001). Quality of informed consent in cancer clinical trials: A cross-sectional survey. The Lancet, 358(9295), 1772-1777. doi:10.1016/S0140-6736(01)06805-2

38.

Johnsson

Helgesson

Rafnar

Halldorsdottir

Chia

K. S.

Eriksson

Hansson

M. G.

(2010). Hypothetical and factual willingness to participate in biobank research. European Journal of Human Genetics, 18, 1261-1264.

39.

Kaufman

Murphy

Scott

Hudson

(2008). Subjects matter: A survey of public opinions about a large genetic cohort study. Genetics in Medicine, 10, 831-839.

40.

Kaye

Whitley

E. A.

Lund

Morrison

Teare

Melham

(2015). Dynamic consent: A patient interface for twenty-first century research networks. European Journal of Human Genetics, 23, 141-146. doi:10.1038/ejhg.2014.71

41.

Kent

(1996). Shared understandings for informed consent: The relevance of psychological research on the provision of information. Social Science & Medicine, 43, 1517-1523.

42.

Khoury

M. J.

Lam

T. K.

Ioannidis

J. P.

Hartge

Spitz

M. R.

Buring

J. E.

. . . Schully

S. D.

(2013). Transforming epidemiology for 21st century medicine and public health. Cancer Epidemiology, Biomarkers & Prevention, 22, 508-516. doi:10.1158/1055-9965.EPI-13-0146

43.

Lewicki

R. J.

Bunker

B. B.

(1995). Trust in relationships: A model of development and decline. In Bunker

Rubin

(Eds.), Conflict, cooperation, and justice: Essays inspired by the work of Morton Deutsch (pp. 133-173). San Francisco, CA: Jossey-Bass.

44.

Lidz

C. W.

(2006). The therapeutic misconception and our models of competency and informed consent. Behavioral Sciences & the Law, 24, 535-546. doi:10.1002/bsl.700

45.

Lipworth

Forsyth

Kerridge

(2011). Tissue donation to biobanks: A review of sociological studies. Sociology of Health & Illness, 33, 792-811.

46.

Lipworth

Morrell

Irvine

Kerridge

(2009). An empirical reappraisal of public trust in biobanking research: Rethinking restrictive consent requirements. Journal of Law and Medicine, 17, 119-132.

47.

Mason

S. A.

Allmark

P. J.

(2000). Obtaining informed consent to neonatal randomised controlled trials: Interviews with parents and clinicians in the Euricon study. The Lancet, 356, 2045-2051.

48.

McCarty

C. A.

Nair

Austin

D. M.

Giampietro

P. F.

(2007). Informed consent and subject motivation to participate in a large, population-based genomics study: The Marshfield Clinic Personalized Medicine Research Project. Community Genetics, 10(1), 2-9.

49.

Meulenkamp

T. M.

Gevers

S. K.

Bovenberg

J. A.

Koppelman

G. H.

van Hylckama Vlieg

Smets

E. M.

(2010). Communication of biobanks’ research results: What do (potential) participants want? American Journal of Medical Genetics Part A, 152, 2482-2492.

50.

Michie

Henderson

Garrett

Corbie-Smith

(2011). “If I could in a small way help”: Motivations for and beliefs about sample donation for genetic research. Journal of Empirical Research on Human Research Ethics, 6(2), 57-70. doi:10.1525/jer.2011.6.2.57

51.

Morris

Balmer

(2006). Volunteer human subjects’ understandings of their participation in a biomedical research experiment. Social Science & Medicine, 62, 998-1008. doi:10.1016/j.socscimed.2005.06.044

52.

Nilsen

R. M.

Vollset

S. E.

Gjessing

H. K.

Skjaerven

Melve

K. K.

Schreuder

. . . Magnus

(2009). Self-selection and bias in a large prospective pregnancy cohort in Norway. Paediatric and Perinatal Epidemiology, 23, 597-608. doi:10.1111/j.1365-3016.2009.01062.x

53.

Nobile

Vermeulen

Thys

Bergmann

M. M.

Borry

(2013). Why do participants enroll in population biobank studies? A systematic literature review. Expert Review of Molecular Diagnostics, 13, 35-47. doi:10.1586/erm.12.116

54.

Nohr

E. A.

Frydenberg

Henriksen

T. B.

Olsen

(2006). Does low participation in cohort studies induce bias? Epidemiology, 17, 413-418. doi:10.1097/01.ede.0000220549.14177.60

55.

Ormond

K. E.

Cirino

A. L.

Helenowski

I. B.

Chisholm

R. L.

Wolf

W. A.

(2009). Assessing the understanding of biobank participants. American Journal of Medical Genetics Part A, 149, 188-198.

56.

Prainsack

Buyx

(2012). Solidarity in contemporary bioethics—Towards a new approach. Bioethics, 26, 343-350. doi:10.1111/j.1467-8519.2012.01987.x

57.

Redelmeier

D. A.

Rozin

Kahneman

(1993). Understanding patients’ decisions. Cognitive and emotional perspectives. Journal of the American Medical Association, 270, 72-76.

58.

Savulescu

Momeyer

R. W.

(1997). Should informed consent be based on rational beliefs? Journal of Medical Ethics, 23, 282-288.

59.

Schreier

(2012). Qualitative content analysis in practice. Thousand Oaks, CA: SAGE.

60.

Steinsbekk

K. S.

Kare Myskja

Solberg

(2013). Broad consent versus dynamic consent in biobank research: Is passive participation an ethical problem? European Journal of Human Genetics, 21, 897-902. doi:10.1038/ejhg.2012.282

61.

Streicher

S. A.

Sanderson

S. C.

Jabs

E. W.

Diefenbach

Smirnoff

Peter

. . . Richardson

L. D.

(2011). Reasons for participating and genetic information needs among racially and ethnically diverse biobank participants: A focus group study. Journal of Community Genetics, 2, 153-163.

62.

Tam

N. T.

Huy

N. T.

Thoa

L. T. B.

Long

N. P.

Trang

N. T.

Hirayama

Karbwang

(2015). Participants’ understanding of informed consent in clinical trials over three decades: Systematic review and meta-analysis. Bulletin of the World Health Organization, 93, 186-198H. doi:10.2471/BLT.14.141390

63.

Thornton

(2009). The UK Biobank project: Trust and altruism are alive and well: A model for achieving public support for research using personal data. International Journal of Surgery, 7, 501-502. doi:10.1016/j.ijsu.2009.09.001

64.

Tutton

(2002). Gift relationships in genetics research. Science as Culture, 11, 523-542. doi:10.1080/0950543022000028965

65.

Verheggen

F. W.

Jonkers

Kok

(1996). Patients’ perceptions on informed consent and the quality of information disclosure in clinical trials. Patient Education and Counseling, 29, 137-153.

66.

Verheggen

F. W.

Nieman

Jonkers

(1998). Determinants of patient participation in clinical studies requiring informed consent: Why patients enter a clinical trial. Patient Education and Counseling, 35, 111-125.

67.

Walker

R. L.

(2009). Respect for rational autonomy. Kennedy Institute of Ethics Journal, 19, 339-366.

68.

World Medical Association. (2013). Declaration of Helsinki: Ethical principles for medical research involving human subjects. Journal of the American Medical Association, 310, 2191-2194. doi:10.1001/jama.2013.281053

69.

Zook

P. M.

Jordan

Adams

Visness

C. M.

Walter

Pollenz

. . . Gern

J. E.

(2010). Retention strategies and predictors of attrition in an urban pediatric asthma study. Clinical Trials, 7, 400-410. doi:10.1177/1740774510373798